Physician

Alcinto Steven Guirand, M.D.

According to 2025 Medicare claims, Alcinto Guirand, M.D. (NPI: 1710243787) practices pain management in the Johnstown, PA market, with the plurality of this provider's patient population coming from Cambria, PA. This provider's primary affiliated billing organization is DLP CONEMAUGH PHYSICIAN PRACTICES LLC (NPI: 1205242609; TIN: 320442710) and primary practice location at 15904-3321. Guirand is affiliated with the AdvantagePoint Health Alliance - Laurel Highlands, LLC (ACO ID: A4657), participating under the MSSP model.

Guirand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 274 traditional Medicare patients, billed 691 HCPCS/CPT codes, and received $47,834 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 339 prescription claims across 161 beneficiaries totaling $24,865 in drug costs, led by Gabapentin (Gabapentin). 2022 DME data shows 12 claims. Open Payments data shows 150 records totaling $2,874. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $15,280 to $24,865. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,114 to $735.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	254	370	$26,068
2018	366	917	$59,352
2019	380	1,013	$74,661
2020	320	999	$71,182
2021	348	893	$64,979
2022	331	891	$64,325
2023	292	842	$58,899
2024	274	691	$47,834

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	27	140	$15,280
2016	N/R	11	$200
2017	344	1,392	$131,364
2018	771	3,720	$455,948
2019	547	2,178	$367,409
2020	562	2,600	$255,966
2021	536	2,501	$289,120
2022	522	2,314	$237,537
2023	387	1,336	$119,569
2024	161	339	$24,865

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$819
2018	26	241	$14,818
2019	20	76	$3,496
2020	N/R	50	$3,168
2021	N/R	14	$792
2022	N/R	12	$735
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	22	30	$92
27096	Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance	72	108	$74
62323	Injection of substance into lower spine canal using imaging guidance	104	152	$65
20610	Aspiration and/or injection of fluid from large joint	30	54	$41
20553	Injection of trigger points, 3 or more muscles	26	37	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gabapentin	Gabapentin	69	3,362	$844
Baclofen	Baclofen	22	874	$512
Methocarbamol	Methocarbamol	34	1,140	$319
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	288	$262
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	391	$236

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	150	$2,874	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alcinto Steven Guirand, M.D.?

Tedicare shows public-source Medicare data for Alcinto Steven Guirand, M.D. (NPI 1710243787), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alcinto Steven Guirand, M.D. have ACO affiliation data?

Alcinto Steven Guirand, M.D. is shown with ACO affiliation data for AdvantagePoint Health Alliance - Laurel Highlands, LLC (MSSP, ACO ID A4657).

What billing organization is linked to Alcinto Steven Guirand, M.D.?

Alcinto Steven Guirand, M.D. is linked to DLP CONEMAUGH PHYSICIAN PRACTICES LLC (billing NPI 1205242609) in the available physician profile data.

Does Alcinto Steven Guirand, M.D. have Open Payments data?

Alcinto Steven Guirand, M.D. has 150 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.